Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,073,124
-$229,265 QoQ
Shares Held
1,885,353
-6.9% QoQ
Ownership
2.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $17,775,077,848 across 529 Biotechnology names. CDXS ranks #229 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,073,124 | 1,885,353 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,302,389 | 2,026,006 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,861,465 | 1,992,404 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,826,000 | 1,977,869 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,179,005 | 1,925,281 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,850,801 | 1,855,514 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,063,639 | 1,644,039 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $5,062,166 | 1,632,957 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,453,749 | 1,562,679 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,618,895 | 1,514,392 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,633,038 | 1,393,142 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,758,448 | 1,342,303 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,097,544 | 1,231,291 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,545 | 1,189,941 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,814,912 | 1,124,573 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,068,709 | 1,058,194 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $22,396,144 | 1,086,137 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $32,665,017 | 1,044,612 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $23,328,617 | 1,002,950 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $22,667,364 | 1,000,325 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $21,449,143 | 937,053 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $18,965,270 | 868,771 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $9,141,351 | 778,650 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,761,891 | 768,587 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $8,292,404 | 743,047 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||